Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06860802 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Precision Antibiotic Dosing for Appendectomy

Study acronym: PANDA
StatusActive, Not Recruiting
PhasePhase 1
Started2025-02-28
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 31 days later Jun 30, 2026 → Jul 31, 2026
See other at-risk trials from University of Michigan

Amendment history

2026-08-12
notable
Study Status, Contacts/Locations v2
Enrollment closed, study ongoing
Primary completion pushed: 2026-06-30 → 2026-07-31
Study sitesdetails revised at 1 of 1 site
2026-03-05
notable
Active, Not Recruiting→Recruiting Study Status, Contacts/Locations v1
Trial statusActive, Not Recruiting→Recruiting
Study sitesdetails revised at 1 of 1 site
2025-02-28
minor
Original filing
This research is studying a drug called cefoxitin already approved by the Food and Drug Administration (FDA) to reduce the risk of infection after surgery to remove an appendix. Researchers are studying a large group of people to continue to learn how best to dose antibiotics. This research will compare the current standard treatment which is a single dose prior to surgery to a new method that includes adding another dose of cefoxitin within 30 minutes of starting the surgery. This study will measure cefoxitin concentrations in blood, fat, and appendix tissue samples to compare the standard dosing method to our new method. This information will help us figure out the right dose of this drug to prevent infection after surgery to remove an appendix.
Trial Details
NCT Number NCT06860802
Lead Sponsor University of Michigan
Collaborators: Agency for Healthcare Research and Quality (AHRQ)
Conditions Appendicitis (Diagnosis)
Enrollment 46 participants
Start Date 2025-02-28
Primary Completion 2026-07-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-08-14